Search results
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 5 days agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...
Scientists Create First Map of a Human Ovary: What to Know
Medscape· 6 days agoFor years, scientists have sought to create a human artificial ovary, restoring fertility in...
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Morningstar· 6 days ago(Nasdaq:DRMA)(Nasdaq;DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions ...
Pain-Management Tips Are All Over TikTok. But What’s Legit?
Washingtonian· 6 days agoDoctors share their insights on trending advice on TikTok.
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 3 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald’s price objective ...
Zacks Research Weighs in on AbbVie Inc.’s FY2024 Earnings (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Zacks Research raised their FY2024 EPS estimates for AbbVie in a note issued to investors on Tuesday, May 14th. Zacks Research analyst ...
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Recommendation of “Hold” by Analysts
ETF DAILY NEWS· 3 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average recommendation of “Hold” from the five ratings firms that are covering the stock, Marketbeat reports. Jefferies Financial ...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 3 days agoMoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report released on Friday, Benzinga reports. HC ...